SensiLase PAD-IQ

Skin Perfusion Pressure Testing - The Intelligent Vascular Test. Fully automated, quantitative evaluation of microcirculatory perfusion for wound healing prediction and PAD detection.

SensiLase PAD-IQ System in clinical use
What is Skin Perfusion Pressure (SPP)?

Skin Perfusion Pressure (SPP) is a noninvasive diagnostic test that provides a fully automated and quantitative evaluation of microcirculatory perfusion in the skin. SPP measures blood flow at a depth of 1.5 to 2.0 mm beneath the skin using a laser Doppler sensor combined with a pressure cuff to evaluate reactive hyperemia.

The SensiLase PAD-IQ system delivers dependable, reproducible measurement of tissue perfusion of the extremities, particularly in patients who have combined peripheral arterial disease (PAD) and diabetes.

Key Capabilities:

  • Skin Perfusion Pressure - Microcirculation (Reactive Hyperemia)
  • Pulse Volume Recording (PVR)
  • Ankle Brachial Index (ABI)
  • Simultaneous Bilateral Testing
  • Wound Image Surface Area Calculation
  • Angiosome-Specific Testing
SPP Interpretive Values

SPP measurements provide objective guidance for wound healing potential and treatment planning:

SPP ValueClassificationClinical Implication
> 50 mmHgAdequate PerfusionHigh wound healing potential
40-50 mmHgMild DiseaseGood healing potential with compliance
30-40 mmHgModerate DiseaseMay require intervention
< 30 mmHgSevere Disease (CLI)Low healing potential without intervention

When SPP is ≥ 35mmHg, surgical debridement of necrotic tissue is feasible without peripheral arterial reconstruction.

Clinical Advantages

Works When Other Tests Cannot

SPP measurements are unaffected by conditions that limit other diagnostic tests:

  • Calcified arteries - Common in diabetic patients
  • Edema - Does not affect accuracy
  • Callused skin - Can test plantar foot
  • Inaudible pulses - No Doppler signal required
  • Anemia/Hypoxia - Measures pressure, not O2

Operational Benefits

  • No calibration required
  • No contact gel or solution needed
  • No heated electrodes
  • Minimal training requirements
  • Touch screen operation - no mouse/keyboard
  • Portable: table, IV pole, or bed mount
  • Telemedicine and EHR compatible
PAD-IQ device on IV pole mount
Device Features
  • Touch Screen Interface - Complete operation without mouse or keyboard
  • Simultaneous Bilateral Testing - Test both limbs at once
  • Fully Automated - Consistent, reproducible results
  • Wound Imaging - Calculate surface area with SmartGuide
  • CPT/ICD Codes - Automatic population for billing
  • Remote Interpretation - Telemedicine compatible
  • EMR Integration - Encrypted data transmission
Clinical Applications

Primary Indications

  • Wound healing prediction
  • Amputation level determination
  • Critical Limb Ischemia (CLI) assessment
  • PAD detection and severity assessment
  • Pre/post revascularization evaluation
  • Diabetic foot assessment

Target Patient Populations

  • Diabetic patients with PAD
  • Patients with chronic wounds
  • Hemodialysis patients
  • Patients with calcified arteries
  • Patients requiring amputation planning
  • Post-endovascular intervention monitoring